Resting Energy Expenditure in Palliative Cancer Patients

Launched by NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY · Jan 4, 2024

Keywords

ClinConnect Summary

This clinical trial, called "Resting Energy Expenditure in Palliative Cancer Patients," is looking to understand the energy needs of patients with incurable cancer who are experiencing weight loss, a condition known as cachexia. The researchers will measure how much energy these patients use while resting and compare it to standard calculations to see if those predictions are accurate. They will also explore other health factors that might affect whether a patient is burning more or less energy than expected. Data will be collected from patient journals, energy measurements, and survival information at one point in time.

To participate in this trial, individuals must be at least 18 years old and have a confirmed diagnosis of an incurable cancer. They need to be hospitalized at the Cancer clinic at St. Olavs Hospital and able to give their consent to join the study. Unfortunately, people with cognitive impairments, those who need extra oxygen, or those on certain breathing machines cannot participate. Participants will have their energy levels measured and will help contribute valuable information that could improve care for future patients with similar conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • A verified diagnosis of an incurable malignant disease
• • Hospitalized at the Cancer clinic, St. Olavs Hospital
• • ≥ 18 years of age
• • Able to provide written informed consent
• • Able to comply with all study procedures
• Exclusion Criteria:
• • Cognitive impairment
• • In need of supplementary oxygen
• • Receiving invasive or noninvasive ventilation